Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss

Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results and Provides Corporate Update

May 10, 2016 4:56 PM EDT

CORAL GABLES, Fla., May 10, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported financial results for the first quarter ended March 31, 2016.

This past quarter has been very challenging, as we were very disappointed by the receipt of the refusal to file letter from the U.S. Food and Drug Administration (FDA) for the Firdapse® new drug application (NDA), said Patrick J. McEnany, Chief Executive Officer of Catalyst. While we are frustrated by... More